Latest News and Press Releases

Vancouver, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global dry eye syndrome market size was USD 5.32 billion in 2022 and is expected to register a revenue CAGR of 7.3% during the forecast period....

New York, July 10, 2023 (GLOBE NEWSWIRE) -- The global dry eye syndrome market is estimated to grow at a CAGR of ~8% from 2023 to 2035. The market is estimated to garner a revenue of ~USD 600...

DUBAI, United Arab Emirates, March 02, 2023 (GLOBE NEWSWIRE) -- The global dry eye syndrome treatment market is anticipated to exceed a value of US$ 8.84 billion by 2032, with sales growing at a...

New York, United States, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The application of artificial tears protects and hydrates mucous membranes and alleviates dryness and irritation of the eyes. Artificial...

MONTREAL, Feb. 03, 2022 (GLOBE NEWSWIRE) -- With the recent launch of its line of dry eye diagnostics, management, and treatment solutions into the United States, I-MED Pharma USA has partnered with...

MONTREAL, Dec. 15, 2021 (GLOBE NEWSWIRE) -- NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and...

MONTREAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Michelle Schnabel to the role of VP Business...

Pune, India, Nov. 09, 2021 (GLOBE NEWSWIRE) -- The global dry eye syndrome market size is expected to reach USD 6.54 billion by 2027, exhibiting a CAGR of 4.7% during the forecast period. The...

MONTREAL, Nov. 08, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Brent Jones to Chief Commercial Officer...

MONTREAL, Nov. 05, 2021 (GLOBE NEWSWIRE) -- I-MED Pharma USA is bringing the world’s most innovative dry eye product portfolio to the U.S. market. Their uniquely formulated line of ocular surface...